Education
About Us
Working with TipRanks
Follow Us
Lasa Supergenerics Ltd. (IN:LASA)
:LASA
LASA Stock Chart & Stats
₹9.16
-₹1.79(-6.22%)
At close: 4:00 PM EST
₹9.16
-₹1.79(-6.22%)
Day’s Range― - ―
52-Week Range₹8.21 - ₹31.40
Previous CloseN/A
Volume56.48K
Average Volume (3M)39.13K
Market Cap
₹458.93M
Enterprise Value₹1.64B
Total Cash (Recent Filing)₹7.90M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Feb 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.25
Shares Outstanding50,101,240
10 Day Avg. Volume9,122
30 Day Avg. Volume39,131
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)1.08
Price to Sales (P/S)0.63
P/FCF Ratio-32.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lasa Supergenerics Ltd. News
LASA FAQ
What was Lasa Supergenerics Ltd.’s price range in the past 12 months?
Lasa Supergenerics Ltd. lowest stock price was ₹8.21 and its highest was ₹31.40 in the past 12 months.
What is Lasa Supergenerics Ltd.’s market cap?
Lasa Supergenerics Ltd.’s market cap is ₹458.93M.
When is Lasa Supergenerics Ltd.’s upcoming earnings report date?
Lasa Supergenerics Ltd.’s upcoming earnings report date is Feb 17, 2026 which is in 57 days.
How were Lasa Supergenerics Ltd.’s earnings last quarter?
Lasa Supergenerics Ltd. released its earnings results on Nov 14, 2025. The company reported -₹1.248 earnings per share for the quarter, missing the consensus estimate of N/A by -₹1.248.
Is Lasa Supergenerics Ltd. overvalued?
According to Wall Street analysts Lasa Supergenerics Ltd.’s price is currently Overvalued.
Does Lasa Supergenerics Ltd. pay dividends?
Lasa Supergenerics Ltd. pays a Annually dividend of ₹0.25 which represents an annual dividend yield of N/A. See more information on Lasa Supergenerics Ltd. dividends here
What is Lasa Supergenerics Ltd.’s EPS estimate?
Lasa Supergenerics Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lasa Supergenerics Ltd. have?
Lasa Supergenerics Ltd. has 50,101,240 shares outstanding.
What happened to Lasa Supergenerics Ltd.’s price movement after its last earnings report?
Lasa Supergenerics Ltd. reported an EPS of -₹1.248 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.67%.
Which hedge fund is a major shareholder of Lasa Supergenerics Ltd.?
Currently, no hedge funds are holding shares in IN:LASA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lasa Supergenerics Ltd.
Lasa Supergenerics Ltd. (LASA) is a leading player in the pharmaceutical and biotechnology sectors, primarily engaged in the manufacturing and marketing of a diverse range of active pharmaceutical ingredients (APIs) and formulations. The company focuses on producing high-quality generics, specialty pharmaceuticals, and veterinary products, catering to both domestic and international markets. LASA is dedicated to innovation and sustainability, utilizing advanced technology to enhance its product offerings and operational efficiency.
Technical Analysis
Aarey Drugs & Pharmaceuticals Ltd.
―
Balaxi Pharmaceuticals Limited
―
Bal Pharma Limited
―
Biofil Chemicals & Pharmaceuticals Ltd.
―
Ind-Swift Ltd.
―